Vaccinex VCNX
OTC VCNX
$0.69 -0.01 (-1.43%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vaccinex, Inc. (VCNX) EBIT Margin (2018 - 2024)

Updated

Vaccinex (VCNX) recorded EBIT Margin of -1590.14% in Q4 2024, up 7163.71 percentage points from the prior quarter.

Analysis

Vaccinex, Inc. (VCNX) EBIT Margin (2018 - 2024) Analysis & Trends

For FY2024, Vaccinex reported EBIT Margin of -3117.30%, up 897.61 percentage points from FY2023.

  • Annual EBIT Margin has a five-year change of +3004.11 percentage points (FY2019 to FY2024).
  • Across earlier years, EBIT Margin came in at -4014.91% in FY2023 (+3223.63 pp), -7238.55% in FY2022 (-4739.66 pp), -2498.89% in FY2021 (+2034.07 pp) and -4532.96% in FY2020 (+1588.45 pp).
  • The Q4 2024 figure is the highest quarterly EBIT Margin since Q1 2023.
  • Per Business Quant, the preceding three quarters came in at -8753.85% (Q3 2024), -2466.38% (Q2 2024) and -4878.85% (Q1 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1,590.14%
Sep 30, 2024 -8,753.85%
Jun 30, 2024 -2,466.38%
Mar 31, 2024 -4,878.85%
Sep 30, 2023 -29,170.00%
Mar 31, 2023 -906.55%
Dec 31, 2022 -2,275.11%
Sep 30, 2022 -9,584.00%
Sep 30, 2021 -10,126.00%
Mar 31, 2021 -734.12%
Sep 30, 2020 -1,373.28%
Sep 30, 2019 -1,900.50%
Jun 30, 2019 -35,432.00%
Mar 31, 2019 -9,723.40%
Dec 31, 2018 -4,412.89%
Sep 30, 2018 -3,259.60%
Jun 30, 2018 -5,203.97%
Mar 31, 2018 -2,771.36%
API Access

Vaccinex, Inc. EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=VCNX&period=max&api_key=YOUR_API_KEY